Michael Donahoe is a Respiratory physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 5th Ave Fl 4
Pittsburgh, PA 152133403
Telephone
412-648-6161Provider last certified this registry record 28 Jul 2021.
Clinical trials
- Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
Sponsor: Michael Donahoe
- Oral Cyclosporine in Chronic Obstructive Pulmonary Disease
Sponsor: Michael Donahoe
- A Study of Inhaled Atropine Sulfate in Healthy Adults
Sponsor: MicroDose Defense Products L.L.C.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
67.1%Corticosteroid37.2%Trelegy Ellipta48%Budesonide-Formoterol Fumarate16%Breo Ellipta7%Symbicort6%Breyna6%Dulera6%Arnuity Ellipta3%Fluticasone Propionate3%Fluticasone Propionate Hfa3%Breztri Aerosphere2%Part D<11 patientsbeta2-Adrenergic Agonist22.9%Albuterol Sulfate Hfa85%Ventolin Hfa15%Part D≥102 patients+ 4 more classes in this area
Metabolism & gastrointestinal
17.8%Corticosteroid13.7%Prednisone100%Part D≥80 patientsProton pump inhibitor2.4%Omeprazole50%Pantoprazole Sodium50%Part D<11 patients+ 1 more class in this area
Anti-infectives
12.2%Macrolide Antimicrobial5.2%Azithromycin100%Part D≥39 patientsPenicillins with extended spectrum3.5%Amoxicillin-Clavulanate Potass100%Part D≥23 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2007–2012 per NIH RePORTER. The latest:
- Clinical Investigation of Aerosol Immunotherapy in COPD
University of Pittsburgh at Pittsburgh
FY2012$330,087P50HL084948 - Clinical Investigation of Aerosol Immunotherapy in COPD
University of Pittsburgh at Pittsburgh
FY2010$330,319P50HL084948 - Clinical Investigation of Aerosol Immunotherapy in COPD
University of Pittsburgh at Pittsburgh
FY2009$300,803P50HL084948
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”